Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer
Authors:
- 24 March 2016
- journal article
- review article
- Published by Springer Nature in Tumor Biology
- Vol. 37 (6) , 7075-7083
Abstract
Transforming growth factor β1 (TGF-β1) is a multifunctional cytokine that plays important roles in cervical tumor formation, invasion, progression, and metastasis. TGF-β1 functions as a tumor inhibitor in precancerous lesions and early stage cancers of cervix whereas as a tumor promoter in later stage. This switch from a tumor inhibitor to a tumor promoter might be due to various alterations in TGF-β signaling pathway, such as mutations or loss of expression of TGF-β receptors and SMAD proteins. Additionally, the oncoproteins of human papillomaviruses have been shown to stimulate TGF-β1 expression, which in turn suppresses host immune surveillance. Thus, in addition to driving tumor cell migration and metastasis, TGF-β1 is believed to play a key role in promoting human papillomavirus infection by weakening host immune defense. In this article, we will discuss the role of TGF-β1 in the expression, carcinogenesis, progression, and therapy in cervical cancers. A better understanding of this cytokine in cervical carcinogenesis is essential for critical evaluation of this cytokine as a potential prognostic marker and therapeutic target.Keywords
Funding Information
- Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents. (No. 201021)
- Grant of Medical and Technology Project of Zhejiang Province (No. 2016KYA141)
This publication has 69 references indexed in Scilit:
- Targeting TGF-β signaling in cancerExpert Opinion on Therapeutic Targets, 2013
- The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patientsDiagnostic Pathology, 2013
- Transforming Growth Factor-β in the Gastrointestinal and Hepatic Tumor MicroenvironmentGastroenterology, 2011
- Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformationCancer Letters, 2009
- Down-regulation of transforming growth factor-β type II receptor (TGF-βRII) protein and mRNA expression in cervical cancerMolecular Cancer, 2008
- High-level inducible Smad4-reexpression in the cervical cancer cell line C4-II is associated with a gene expression profile that predicts a preferential role of Smad4 in extracellular matrix compositionBMC Cancer, 2007
- Molecular profiling of cervical cancer progressionBritish Journal of Cancer, 2007
- Prognostic relevance of TGF‐β1 and PAI‐1 in cervical cancerInternational Journal of Cancer, 2004
- Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancerOncogene, 2003
- Aberrant expression of Smad4 results in resistance against the growth‐inhibitory effect of transforming growth factor‐β in the SiHa human cervical carcinoma cell lineInternational Journal of Cancer, 2001